规格
|
|
Endotoxin Level:
|
< 1 EU/µg |
|
Product Line:
|
Sino Biological® |
|
Protein:
|
Tumor necrosis factor receptor superfamily, member 9 |
|
Expression System:
|
Mammalian |
|
Form:
|
Lyophilized |
|
Protein Family:
|
CD Proteins, Cytokines & Receptors |
|
Protein Subtype:
|
TNF Receptors |
|
Research Category:
|
Immunology, Drug Development, Oncology |
|
Species:
|
Human |
|
Validated Application:
|
Assay Standard |
|
Molecular Weight:
|
45.2 kDa |
|
Purity:
|
≥ 90% by SDS-PAGE |
|
Gene Alias:
|
4-1BB, CD137, CDw137, ILA, MGC2172, TNFRSF9 |
|
Gene Symbol:
|
TNFRSF9 |
|
Protein Tag:
|
IgG1 Fc Tag, His Tag |
储存
|
|
Includes 5 vial of lyophilized protein. Store at -20 °C. |
Tumor Necrosis Factor Receptor Super Family 9 (TNFRSF9), recombinant human/mouse protein is supplied as a lyophilized powder. It is suitable for use in protein studies such as protein structure analysis and protein-protein interactions. In general, recombinant proteins can also be used as an immunogen, as a protein standard, or in cell biology research applications.
This recombinant protein was expressed from a DNA sequence encoding the N-terminal fragment (Met 1-Gln 186) of the extracellular domain of human TNFRSF9 (NP_001552.2) fused with the C-terminal polyhistidine-tagged Fc region of human IgG1 at the C-terminus.
Activity: Measured by its binding ability in a functional ELISA
. Immobilized recombinant mouse 4-1BB Ligand at 20µg/ml (100 µl/well) can bind human 4-1BB with a linear range of 15.6-500 ng/ml
.
Formulation: Lyophilized in 140 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 1.8 mM KH2PO4, pH 7.4, 5% Mannitol, 5% Trehalose, 0.02% Tween 80.
Reconstitution: Dissolve the protein in sterile double distilled water to a concentration of 0.2 mg/ml or lower. It is recommended that the protein be aliquoted and be used as soon as possible. Store aliquots under sterile conditions at -20°C. Avoid repeated freeze-thaw cycles.
Expiration Date: Expires one year from date of receipt when stored as instructed.
This protein is manufactured by Sino Biological Inc.